LabGenomics Co., Ltd. (KOSDAQ:084650)
2,175.00
+5.00 (0.23%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Medical Diagnosis | 85.91B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Diagnosis Growth | 17.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Venture Investment | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Venture Investment Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Other | 45.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 50.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 135.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 34.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -31.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 326.38M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -34.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 122.06M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | -81.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 45.23M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|